Brain Cancer Canada awards
Sunnybrook Health Sciences Centre
$50,000 to Improve Survival
Rates for Glioblastoma and Other Gliomas

Brain Cancer Canada is delighted to announce a $50,000 research grant 🔬 to Dr. Amit Singnurkar at Sunnybrook Health Sciences Centre. The grant will support a ground-breaking study to improve the treatment of glioblastoma and other high-grade gliomas. The goal is to use advanced FET-PET/MRI imaging to detect and treat tumour cells left over after surgery, which could spare healthy brain tissue and minimize side effects.

Dr. Singnurkar’s pioneering research aims to revolutionize the detection and treatment of residual tumour cells after surgery, which is currently a significant challenge. The research uses advanced FET-PET/MRI imaging to provide clinicians with more accurate information.

“We are hopeful that this research will make a significant difference in the treatment of high-grade gliomas,” Dr. Singnurkar said. “If successful, this new imaging technique will enable us to provide more precise and personalized treatment plans, sparing healthy brain tissue and minimizing patient side effects.”

Click for official press release:
https://www.globenewswire.com/news-release/2023/05/25/2676376/0/en/Brain-Cancer-Canada-Grants-Research-Funds-to-Improve-Survival-Rates-for-Glioblastoma-and-Other-Gliomas.html